Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
International Journal of Environmental Research and Public Health|July 29, 2025
A Rapid Review of Ethical and Equity Dimensions in Telerehabilitation for Physiotherapy and Occupational TherapyMirella Veras, Jennifer Sigouin, Louis-Pierre Auger, et al.BMJ Open|July 28, 2025
Short-term effects of a virtual, community-based, task-oriented group exercise programme incorporating a healthcare-community partnership compared to a waitlist control on increasing everyday function among adults with mobility limitations: protocol for the TIME™ at Home randomised controlled trialNancy Margaret Salbach, C Allyson Jones, Ruth Barclay, et al.ACS Medicinal Chemistry Letters|September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-OncologyMin Lu, Hongjun Zhang, Derun Li, et al.ACS Medicinal Chemistry Letters|April 16, 2020
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer ImmunotherapyMatthew J Mitcheltree, Derun Li, Abdelghani Achab, et al.Communications Biology|July 30, 2021
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of actionRachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.Molecular Cancer Therapeutics|November 29, 2023
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical StudiesEkta Patel, Natalia V Malkova, David Crowe, et al.Nature|May 23, 2007
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersRichard S Maser, Bhudipa Choudhury, Peter J Campbell, et al.Journal of Medicinal Chemistry|May 5, 2026
Discovery of MK-1088 as a Potent A2A/A2B Adenosine Receptor Dual-Antagonist for Cancer ImmunotherapyYonglian Zhang, Elisabeth Hennessy, Matthew A Larsen, et al.Pageof 7